Page 4 - Antipsychotics News Today

Academics and researchers in psychiatry and psychopharmacology criticize a review that questions the serotonin hypothesis of depression ― a bedrock principle of depression treatment.

In addition to reducing negative symptoms of schizophrenia, music therapy improves sleep and symptoms of depression.

The antipsychotic brexpiprazole (Rexulti) is the first FDA-approved treatment option for agitation associated with Alzheimers disease.

Dexmedetomidine is the current darling for improving sleep in patients in the ICU. But does the evidence support it?

The antipsychotic improves on standard antiemetic therapy in patients known to be more prone to nausea and vomiting with chemotherapy.

The company has sued the federal government over accusations that the FDA passed trade secrets about its schizophrenia drug Fanapt and sleep-disorder medication Hetlioz to generic competitors.

A large proportion of US adults prescribed Schedule II stimulants are simultaneously receiving other CNS agents, including benzodiazepines, opioids, and antidepressants.

Compared to the antipsychotic clozapine, the other antipsychotic medications were linked to higher odds of having insomnia or sleeplessness.

There are limited data on potential disparities in dementia medication use in the outpatient setting, with study authors highlighting that the benefits of these medications are not equitably distributed along racial and ethnic lines because of usage differences.

Compared to placebo, the Alzheimers drug memantine significantly reduces symptoms of trichotillomania and skin picking, results of a randomized clinical trial show.